Paragon 28, Inc. (FNA)
NYSE: FNA · Real-Time Price · USD
10.88
+0.22 (2.06%)
Jan 17, 2025, 4:00 PM EST - Market closed
Paragon 28 Revenue
Paragon 28 had revenue of $62.34M in the quarter ending September 30, 2024, with 18.10% growth. This brings the company's revenue in the last twelve months to $245.00M, up 18.16% year-over-year. In the year 2023, Paragon 28 had annual revenue of $216.39M with 19.30% growth.
Revenue (ttm)
$245.00M
Revenue Growth
+18.16%
P/S Ratio
3.69
Revenue / Employee
$426,821
Employees
574
Market Cap
910.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 216.39M | 35.01M | 19.30% |
| Dec 31, 2022 | 181.38M | 33.92M | 23.00% |
| Dec 31, 2021 | 147.46M | 36.48M | 32.87% |
| Dec 31, 2020 | 110.98M | 4.70M | 4.42% |
| Dec 31, 2019 | 106.28M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.22B |
FNA News
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Shareholders to Reach Out - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 7 days ago - Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 - Business Wire
- 8 days ago - Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Shareholders to Inquire about Securities Investigation - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Investors to Connect - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Stockholders to Inquire about Securities Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Investors to Learn More About the Investigation - Accesswire